PB
EW icon

Prosperity Bancshares’s Edwards Lifesciences EW Stock Holding History

Prosperity Bancshares’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Hold
123
– – 0.01% 320
2026
Q1 		$9.85K Hold
123
– – 0.01% 316
2025
Q4 		$10.5K Buy
+123
New +$10.1K 0.01% 287

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Prosperity Bancshares's EW Position: Q2 2026 in Review

Prosperity Bancshares held its Edwards Lifesciences (EW) position steady in Q2 2026 at 123 shares worth $11.1K. The position accounts for 0.01% of the portfolio, ranked #320.

Prosperity Bancshares first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Prosperity Bancshares held 123 shares of Edwards Lifesciences worth $11.1K as of Q2 2026.
  • Prosperity Bancshares left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Prosperity Bancshares's portfolio in Q2 2026, its #320 holding.
  • Prosperity Bancshares first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Prosperity Bancshares's 13F filing for Q2 2026, filed 14 Aug 2026.